Haleon reported 676M in Cash and Equivalent for its fiscal quarter ending in June of 2025.


Cash And Equivalent Change Date
AstraZeneca USD 7.06B 1.83B Jun/2025
Edgewell Personal Care USD 199.6M 29.5M Jun/2025
Energizer USD 171.1M 31.8M Jun/2025
Haleon 676M 1.52B Jun/2025
L'Oréal EUR 4.82B 769.6M Jun/2025
Nestle CHF 4.65B 904M Jun/2025
Reckitt Benckiser GBP 880M 106M Dec/2024
Unilever EUR 6.14B 1.17B Dec/2024